In terms of clinical syndromes experienced at any point during the disease course, MOG-antibody positive patients were more likely to have experienced optic neuritis (74 vs. 40%) or brainstem (38 vs. 21%) presentations than the seronegative group. Here, MOG is linked to optic neuritis.